PMID- 32226609 OWN - NLM STAT- MEDLINE DCOM- 20200818 LR - 20220826 IS - 2046-1402 (Electronic) IS - 2046-1402 (Linking) VI - 9 DP - 2020 TI - Recent advances in mast cell activation and regulation. LID - F1000 Faculty Rev-196 [pii] LID - 10.12688/f1000research.22037.1 [doi] AB - Mast cells are innate immune cells that intersect with the adaptive immunity and play a crucial role in the initiation of allergic reactions and the host defense against certain parasites and venoms. When activated in an allergen- and immunoglobulin E (IgE)-dependent manner, these cells secrete a large variety of allergenic mediators that are pre-stored in secretory granules or de novo-synthesized. Traditionally, studies have predominantly focused on understanding this mechanism of mast cell activation and regulation. Along this line of study, recent studies have shed light on what structural features are required for allergens and how IgE, particularly anaphylactic IgE, is produced. However, the last few years have seen a flurry of new studies on IgE-independent mast cell activation, particularly via Mrgprb2 (mouse) and MRGPRX2 (human). These studies have greatly advanced our understanding of how mast cells exert non-histaminergic itch, pain, and drug-induced pseudoallergy by interacting with sensory neurons. Recent studies have also characterized mast cell activation and regulation by interleukin-33 (IL-33) and other cytokines and by non-coding RNAs. These newly identified mechanisms for mast cell activation and regulation will further stimulate the allergy/immunology community to develop novel therapeutic strategies for treatment of allergic and non-allergic diseases. CI - Copyright: (c) 2020 Kim HS et al. FAU - Kim, Hwan Soo AU - Kim HS AUID- ORCID: 0000-0002-5952-7849 AD - Division of Cell Biology, La Jolla Institute for Immunology, La Jolla, California, 92037, USA. AD - Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, South Korea. FAU - Kawakami, Yu AU - Kawakami Y AD - Division of Cell Biology, La Jolla Institute for Immunology, La Jolla, California, 92037, USA. FAU - Kasakura, Kazumi AU - Kasakura K AD - Division of Cell Biology, La Jolla Institute for Immunology, La Jolla, California, 92037, USA. FAU - Kawakami, Toshiaki AU - Kawakami T AUID- ORCID: 0000-0002-0427-1217 AD - Division of Cell Biology, La Jolla Institute for Immunology, La Jolla, California, 92037, USA. AD - Department of Dermatlogy, University of California San Diego, School of Medicine, La Jolla, CA, 92093, USA. LA - eng GR - R01 AI146042/AI/NIAID NIH HHS/United States GR - R21 AI153867/AI/NIAID NIH HHS/United States GR - T32 AI125179/AI/NIAID NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20200319 PL - England TA - F1000Res JT - F1000Research JID - 101594320 RN - 0 (Allergens) RN - 0 (Cytokines) RN - 0 (MRGPRX2 protein, human) RN - 0 (Nerve Tissue Proteins) RN - 0 (Receptors, G-Protein-Coupled) RN - 0 (Receptors, Neuropeptide) RN - 37341-29-0 (Immunoglobulin E) SB - IM MH - Allergens MH - Animals MH - Cytokines MH - Humans MH - Immunoglobulin E MH - *Mast Cells MH - Nerve Tissue Proteins MH - Receptors, G-Protein-Coupled MH - Receptors, Neuropeptide PMC - PMC7096214 OTO - NOTNLM OT - Allergy OT - FcepsilonRI OT - IL-33 OT - IgE OT - MRGPRX2 OT - allergen OT - mast cells OT - miRNA COIS- No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed. EDAT- 2020/04/01 06:00 MHDA- 2020/08/19 06:00 PMCR- 2020/03/19 CRDT- 2020/04/01 06:00 PHST- 2020/03/06 00:00 [accepted] PHST- 2020/04/01 06:00 [entrez] PHST- 2020/04/01 06:00 [pubmed] PHST- 2020/08/19 06:00 [medline] PHST- 2020/03/19 00:00 [pmc-release] AID - F1000 Faculty Rev-196 [pii] AID - 10.12688/f1000research.22037.1 [doi] PST - epublish SO - F1000Res. 2020 Mar 19;9:F1000 Faculty Rev-196. doi: 10.12688/f1000research.22037.1. eCollection 2020.